ZYNERBA PHARMACEUTICALS, INC.: capex

Value{"amount": 24616, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2019-01-01 – 2019-03-31
Statuscurrent
EntityZYNERBA PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001558370-19-004373 · Open the official SEC filing →
Retrieved: 2026-08-19T16:40:57.256000+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001621443/capex/2019-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/ede4aedd-3934-4917-9d9e-ce3a3be80c0b

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies